SME Times is powered by   
Search News
Just in:   • Adani Group to invest Rs 57,575 crore in Odisha  • 'Dollar Distancing' finally happening? Time for India to pitch Rupee as credible alternative: SBI Ecowrap  • 49% Indian startups now from tier 2, 3 cities: Jitendra Singh  • 'India ranks 3rd in global startup ecosystem & number of unicorns'  • LinkedIn lays off entire global events marketing team: Report 
Last updated: 27 Sep, 2014  

Nova IVI Fertility Launches New Center in Jalandhar

PR Newswire | 13 Mar, 2014
JALANDHAR, India: Infertility is on the rise in India due to numerous reasons including genetic disorders, stress, urbanization, late settlement in life as well as the rising incidence of an unhealthy lifestyle. A recent study estimates approximately 15%-20% of married couples in their fertile age group suffer from infertility. It is an increasingly prevalent health concern and treatments are widely being sought to overcome infertility related disorders. However, there is a widespread shortage of standardized clinical protocols, structured training, quality laboratories, qualified embryologists and ethical practices.

Filling in this gap and bringing to fore a trusted and a credible partner offering standardised and ethical infertility treatment to couples with the latest techniques, Nova IVI Fertility launched its 7th center in India in the city of Jalandhar today. Part of Nova Medical Centers, the Nova IVI Fertility center in Jalandhar was inaugurated by Manpreet Singh Chattwal, Commissioner, Municipal Corporation, in the presence of Suresh Soni, Chairman and CEO, Nova Medical Centers, V.P. Kamath, Group COO, Nova Medical Centers and Dr. Jasmine Kaur, Clinical Director, Nova IVI Fertility - Jalandhar.

Speaking at the launch, Suresh Soni, Chairman and CEO, Nova Medical Centers, said, "We are extremely happy to announce the opening of our center in Jalandhar, which will also act as a focal point catering to nearby areas in the state of Punjab. This center brings together renowned specialists with state-of-the-art technology and extensive services all under one roof. The new facility in Jalandhar is a step ahead in realising Nova's commitment towards offering standardised and ethical infertility treatment, as well as addressing the urgent need for an organized institutional provider for fertility treatment. With six well-established fertility centers in major cities and the seventh one in Jalandhar, Nova IVI Fertility plans to launch as many as 10 centers in a year's time with the goal of bringing high quality assisted reproductive therapy to the people of India."

In addition to providing core procedures such as IUI, IVF, and Andrology services, Nova IVI Fertility - Jalandhar will offer several state-of-the-art technologies such as assisted hatching, blastocyst culture, and vitrification. This center will also offer another sought after advanced technique known as IMSI (intracytoplasmic morphologically-selected sperm injection). This is an upgrade of ICSI (intracytoplasmic sperm injection), where the embryologist carries out the fertilization of the oocytes (egg) using an extremely high-powered microscope to select the sperm cells with the best morphological quality.

Dr. Jasmine Kaur, Clinical Director, Nova IVI Fertility, Jalandhar, added, "In my career, I have come across hundreds of couples wanting to have children but who have been unlucky. With my experience, I have learnt that with a little patience, compassion and the right technology, we can bring joy into the lives of our patients. Nova IVI Fertility center at Jalandhar is fully equipped with the latest technology available in the world and offers the most effective treatment to patients, while following international guidelines to ensure positive results."

Nova IVI stems from a partnership between Nova Medical Centers and IVI, Spain, to introduce the most sophisticated advanced Assisted Reproductive Technology in India. This partnership has resulted in substantial addition to Nova's IVF services and technology, including proprietary software, training and quality management. With IVI's know-how and vast international expertise, Nova brings the same exceptional standard of processes, protocols and policies that has helped thousands of births. More importantly, the Nova IVI ART Bank now provides oocyte freezing (vitrification) and Pre-implantation Genetic Diagnosis (PGD) in India. This successful partnership has helped establish a world-class research facility in India that has the most robust database for clinical research in the field of infertility treatments, making Nova IVI a market leader in ART and clinical outcomes.

Nova IVI Fertility is already present in Ahmedabad, Bengaluru, Kolkata, Mumbai, New Delhi and Chennai.

About Nova Medical Centers

Nova Medical Centers is the parent company of Nova Specialty Hospitals and Nova IVI Fertility. It currently operates 11 specialty surgery centers and 7 fertility centers. Nova was co-founded by Suresh Soni, renowned shoulder surgeon Dr. Mahesh Reddy and the GTI Group, based on a "doctor-owned and doctor-managed" concept enabling doctors to have a sense of ownership and a long-term association with the company. This concept also allows doctors to deliver the best possible patient care in an open and free environment.

Established in 2009, Nova Specialty Hospitals' mission is to provide world-class surgical care that is accessible and at an affordable cost. Having pioneered the concept of short-stay surgical care in India, Nova focuses on providing the finest quality care for patients from specialized doctors while increasing operating efficiency.

Nova IVI Fertility is a joint venture between Nova Pulse, India, and IVI, Spain, introducing the same exceptional standard of processes, protocols and policies to deliver the most sophisticated Assisted Reproductive Technology (ART) in India.

Nova's vision is to create a novel institution that stands for excellence in healthcare services by providing the best patient experience and is an international reference for clinical outcomes, by adopting the latest advances in medical sciences, technology and an innovative business model.

For further information, please visit,

Google Plus:

Primary Media Contact: Parul Vaid,, 91-9873212501

Secondary Media Contact: Megha Kapoor,, 91-9811656488

Print the Page Add to Favorite
Share this on :

Please comment on this story:
Subject :
(Maximum 1500 characters)  Characters left 1500
Your name:

  Customs Exchange Rates
Currency Import Export
US Dollar
UK Pound
Japanese Yen 58.85 56.85
As on 13 Aug, 2022
  Daily Poll
PM Modi's recent US visit to redefine India-US bilateral relations
 Can't say
  Commented Stories
» GIC Re's revenue from obligatory cession threatened(1)
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter